
University of California,
San Diego (UCSD)
Rebecca and John Moores UCSD
Cancer Center
La Jolla, CA
Bart's Cancer Centre of
Excellence
Barts Hospital
West Smithfield, London
The Burnham Institute
La Jolla, CA
Dana Farber Cancer Institute
Harvard Medical School
Boston, MA
Long Island Jewish Medical
Center
Division of Hematology/Oncology
New Hyde Park, NY
Mayo Clinic
Rochester, MN
M.D. Anderson Cancer Center
Houston, TX
Ohio State University
Cancer Center
Columbus, Ohio
2007
Prognostic Nomogram for overall survival (2/13/2007)
2006
Update: Zap-70 (10/1/2006)
Von Eschenbach Will Resign as Director of the NCI (6/1/2006)
Flavopiridol for Previously Treated Chronic Lymphocytic Leukemia (Posted 5/30/2006)
CD154 induces P73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional P53 (Blood, Posted 4/1/2006)
Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL (Blood, Posted 1/3/2006)
2005
Activity of Unusual Genes Distinguishes Dangerous Leukemia (10/21/2005)
Thinking Big with The Very Small: Focus of New Cancer Nanotechnology Center at UCSD (Posted 10/3/2005)
Unusual RNAs Linked to Chronic Leukemia, May Help Treat It
NIH Selects Burnham Institute for Exploratory Center for Human Embryonic Stem Cell Research (Posted 8/9/2005)
Moores UCSD Cancer Center Hosts CLL Symposium (posted 4/3/2005)
Scientists Disprove Two Tenets of Common Leukemia (Posted 2/10/2005)
Some Relapsed CLL Patients Have Remissions Campath-1H and Rituxan Used With Chemotherapy (Posted 1/16/2005)
1/2005
8/2004